Sun Pharma Advanced Research Company Ltd
NSE: SPARC BSE: 532872
₹114.89
(-4.96%)
Wed, 01 Apr 2026, 10:35 am
Market Cap37.19B
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KSun Pharma Advanced Research Company Financials
| Particulars | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 374.63M | 351.42M | 344.07M | 583.48M | 289.76M | 872.79M | 1.67B | 1.56B | 1.61B | 1.81B | 782.59M | 1.83B | 768.14M | 2.53B | 1.37B | 2.39B | 755.45M | 717.66M |
| Gross profit | -18.34M | 361.95M | -115.85M | -172.45M | 126.31M | -684.46M | -148.79M | 353.75M | -323.25M | -551.30M | -862.31M | -1.89B | 652.58M | -893.90M | 1.05B | -35.91M | 821.21M | -1.24B | -1.34B |
| Operating expenses (excl. COGS) | -51.00K | -169.30M | -5.82M | -44.24M | -222.32M | -46.32M | -50.85M | -54.37M | -98.86M | -152.96M | -445.42M | -619.74M | -2.17B | -2.26B | -2.51B | -1.92B | -3.06B | -2.88B | -2.00B |
| Selling/general/admin expenses, total | — | -168.28M | — | -43.12M | -221.81M | -44.75M | -49.42M | -50.89M | -97.44M | -148.66M | -443.75M | -617.86M | -2.17B | -2.25B | -2.51B | -1.92B | -3.06B | -2.88B | -2.00B |
| Research & development | — | — | — | — | — | — | — | — | — | — | — | — | -1.48B | -3.87B | -3.88B | -3.24B | -4.53B | -4.79B | -3.99B |
| Selling/general/admin expenses, other | — | -168.28M | — | -43.12M | -221.81M | -44.75M | -49.42M | -50.89M | -97.44M | -148.66M | -443.75M | -617.86M | -693.94M | 1.61B | 1.37B | 1.32B | 1.47B | 1.92B | 1.99B |
| Other operating expenses, total | -51.00K | -1.02M | -5.82M | -1.12M | -509.00K | -1.57M | -1.43M | -3.48M | -1.41M | -4.30M | -1.67M | -1.88M | -827.00K | -1.62M | -1.59M | -1.71M | -1.36M | -1.29M | -1.30M |
| Operating income | -18.39M | -46.63M | -121.67M | -216.69M | -96.01M | -730.78M | -199.64M | 299.38M | -422.10M | -704.26M | -1.31B | -2.51B | -1.52B | -3.15B | -1.46B | -1.96B | -2.24B | -4.12B | -3.34B |
| Non-operating income, total | 41.00K | 513.00K | -3.76M | 1.23M | 11.08M | 8.46M | -25.31M | 43.87M | 26.90M | 4.34M | 117.35M | 537.77M | 66.87M | 25.51M | -54.37M | -73.23M | 10.61M | 246.72M | -87.17M |
| Interest expense, net of interest capitalized | — | -135.00K | -2.43M | -1.75M | -1.28M | -2.75M | -39.51M | -55.97M | -2.18M | -21.57M | -18.20M | -1.23M | -939.00K | -26.75M | -106.50M | -133.29M | -76.35M | -11.75M | -84.57M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 41.00K | 648.00K | -1.34M | 2.98M | 12.36M | 11.21M | 14.20M | 52.89M | 28.57M | 25.91M | 134.60M | 537.54M | 25.20M | 46.95M | 52.09M | 59.93M | 75.11M | 258.45M | -2.60M |
| Non-operating interest income | 40.00K | 745.00K | 730.00K | 598.00K | 3.46M | 5.77M | 7.19M | 39.00M | 27.59M | 7.32M | 116.47M | 6.36M | 31.36M | 29.32M | 8.97M | 14.10M | 75.95M | 254.76M | 6.82M |
| Miscellaneous non-operating expense | 1.00K | -97.00K | -2.07M | 2.39M | 8.90M | 5.43M | 7.01M | 13.89M | 983.00K | 18.59M | 18.13M | 531.18M | -6.16M | 17.63M | 43.12M | 45.83M | -845.00K | 3.70M | -9.42M |
| Unusual income/expense | — | — | — | — | — | — | — | 46.95M | 510.00K | — | 944.00K | 1.46M | 42.60M | 5.31M | 41.00K | 128.00K | 11.85M | 14.00K | 0 |
| Pretax income | -18.35M | -46.12M | -125.43M | -215.46M | -84.93M | -722.32M | -224.95M | 343.24M | -395.20M | -699.92M | -1.19B | -1.97B | -1.45B | -3.12B | -1.51B | -2.03B | -2.23B | -3.87B | -3.43B |
| Taxes | -31.49M | -2.71M | 34.03M | -75.00K | -79.00K | 0 | 0 | -40.00M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.82M | 2.72M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | -49.84M | -48.83M | -91.41M | -215.53M | -85.01M | -722.32M | -224.95M | 303.24M | -395.20M | -699.92M | -1.19B | -1.97B | -1.45B | -3.12B | -1.51B | -2.03B | -2.23B | -3.87B | -3.43B |
| Net income | -49.84M | -48.83M | -91.41M | -215.53M | -85.01M | -722.32M | -224.95M | 303.24M | -395.20M | -699.92M | -1.19B | -1.97B | -1.45B | -3.12B | -1.51B | -2.03B | -2.23B | -3.87B | -3.43B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | -49.84M | -48.83M | -91.41M | -215.53M | -85.01M | -722.32M | -224.95M | 303.24M | -395.20M | -699.92M | -1.19B | -1.97B | -1.45B | -3.12B | -1.51B | -2.03B | -2.23B | -3.87B | -3.43B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | -17.39M | 205.33M | -103.31M | -190.70M | -66.15M | -699.15M | -162.90M | 337.88M | -346.92M | -625.69M | -1.23B | -2.43B | -1.45B | -3.05B | -1.35B | -1.86B | -2.12B | -3.99B | -3.22B |
| EBIT | -18.39M | 192.66M | -121.67M | -216.69M | -96.01M | -730.78M | -199.64M | 299.38M | -422.10M | -704.26M | -1.31B | -2.51B | -1.52B | -3.15B | -1.46B | -1.96B | -2.24B | -4.12B | -3.34B |
| Total operating expenses | -18.39M | -421.26M | -473.09M | -560.76M | -679.49M | -1.02B | -1.07B | -1.37B | -1.98B | -2.32B | -3.12B | -3.29B | -3.35B | -3.92B | -3.99B | -3.33B | -4.62B | -4.87B | -4.06B |
| Prepaid expenses | — | 2.67M | 5.71M | 4.65M | 4.29M | 2.18M | 3.59M | 41.30M | 30.51M | 7.46M | 44.24M | 40.69M | 74.93M | 53.40M | 55.87M | 35.54M | 43.94M | 62.98M | 55.51M |
| Deferred income, current | — | — | — | — | — | — | — | — | — | 32.30M | 31.50M | 31.50M | 3.05M | 2.70M | 2.70M | 292.00K | 11.00K | 166.82M | 579.94M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 58.33M | 42.15M | 24.37M | 126.20M | 106.61M | 69.49M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 31.49M | 38.00M | 135.91M | 150.45M | — | — | — | 197.50M | 206.18M | 218.90M | 235.28M | 143.46M | — | — | — | — | — | — | — |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | — | — | 392.43M | 392.43M | 668.45M | 1.18B | 1.03B | 625.98M |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800